Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ramírez de Arellano, Antonio
1435  Ergebnisse:
Personensuche X
?
1

Cost analysis of patiromer versus sodium zirconium cyclosil..:

Ramirez de Arellano, Antonio ; Jakutis, Gabrielius ; Hunt, Barnaby
Journal of Medical Economics.  , 2024
Link: https://doi.org/10.1080/..
 
?
2

Profile, Healthcare Resource Consumption and Related Costs ..:

Degli Esposti, Luca ; Dovizio, Melania ; Perrone, Valentina...
Advances in Therapy.  40 (2023)  12 - p. 5338-5353 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Clinical and economic impact of ferric carboxymaltose treat..:

McEwan, Phil ; Ponikowski, Piotr ; Shiri, Tinevimbo...
Journal of Medical Economics.  26 (2022)  1 - p. 51-60 , 2022
Link: https://doi.org/10.1080/..
 
?
4

Cost-Effectiveness of Intravenous Iron Formulations in Pati..:

Ramirez de Arellano, Antonio ; Norton, Nicholas ; Enkusson, Dana...
GastroHep.  2022 (2022)  - p. 1-10 , 2022
Link: https://doi.org/10.1155/..
 
?
5

Incidence, Treatment and Clinical Impact of Iron Deficiency..:

Miñana, Gema ; Lorenzo, Miguel ; Ramirez de Arellano, Antonio...
Journal of Clinical Medicine.  11 (2022)  9 - p. 2559 , 2022
Link: https://doi.org/10.3390/..
 
?
6

A cost-effectiveness analysis of patiromer for the treatmen..:

González-Juanatey, José Ramón ; González-Franco, Álvaro ; de Sequera, Patricia...
Journal of Medical Economics.  25 (2022)  1 - p. 640-649 , 2022
Link: https://doi.org/10.1080/..
 
?
7

A Response to: Letter to the Editor Regarding 'Iron Formula..:

Aksan, Aysegül ; Schoepfer, Alain ; Juillerat, Pascal...
Advances in Therapy.  39 (2021)  1 - p. 815-821 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Estimating hospital inpatient cost-savings with sucroferric..:

Herrero, Jose Antonio ; Salomone, Mario ; Ramirez de Arellano, Antonio..
Journal of Medical Economics.  24 (2021)  1 - p. 1240-1247 , 2021
Link: https://doi.org/10.1080/..
 
?
9

Ferric carboxymaltose for the treatment of iron deficiency ..:

McEwan, Phil ; Ponikowski, Piotr ; Davis, Jason A....
European Journal of Heart Failure.  23 (2021)  10 - p. 1687-1697 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Evaluation of the Cost-Effectiveness of Iron Formulations f..:

Aksan, Aysegül ; Beales, Ian LP ; Baxter, Garth...
ClinicoEconomics and Outcomes Research.  13 (2021)  - p. 541-552 , 2021
Link: https://doi.org/10.2147/..
 
?
11

Iron Formulations for the Treatment of Iron Deficiency Anem..:

Aksan, Aysegül ; Schoepfer, Alain ; Juillerat, Pascal...
Advances in Therapy.  38 (2020)  1 - p. 660-677 , 2020
Link: https://doi.org/10.1007/..
 
?
12

Estimating the Epidemiological and Economic Impact of Imple..:

Drabinski, Thomas ; Zacharowski, Kai ; Meybohm, Patrick..
Advances in Therapy.  37 (2020)  8 - p. 3515-3536 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Erratum to: The Economic Burden of Insulin-Related Hypoglyc..:

Parekh, Witesh ; Hoskins, Nicki ; Baker-Knight, James..
Diabetes Therapy.  8 (2017)  5 - p. 1195-1196 , 2017
Link: https://doi.org/10.1007/..
 
?
14

Cost-effectiveness analysis of IDegLira versus basal-bolus ..:

Psota, Marek ; Psenkova, Maria ; Racekova, Natalia...
ClinicoEconomics and Outcomes Research.  9 (2017)  - p. 749-762 , 2017
Link: https://doi.org/10.2147/..
 
?
15

The Economic Burden of Insulin-Related Hypoglycemia in Spai:

Parekh, Witesh ; Hoskins, Nicki ; Baker-Knight, James..
Diabetes Therapy.  8 (2017)  4 - p. 899-913 , 2017
Link: https://doi.org/10.1007/..
 
1-15